Catecholamine production and tyrosine hydroxylase expression in peripheral blood mononuclear cells from multiple sclerosis patients: effect of cell stimulation and possible relevance for activation-induced apoptosis

被引:82
作者
Cosentino, M
Zaffaroni, M
Marino, F
Bombelli, R
Ferrari, M
Rasini, E
Lecchini, S
Ghezzi, A
Frigo, G
机构
[1] Univ Insubria, Fac Med, Pharmacol Lab, Ctr Res Clin & Appl Pharmacol, I-21100 Varese, VA, Italy
[2] Univ Pavia, Ctr Res Clin Apl Pharmacol, I-27100 Pavia, Italy
[3] Univ Insubria, Pharmacol Lab, Varese, Italy
[4] Univ Milan, Hosp S Antonio Abate, Multiple Sclerosis Ctr, Gallarate, VA, Italy
关键词
multiple sclerosis; peripheral blood mononuclear cells; catecholamines; dopamine; tyrosine hydroxylase; phytohaemagglutinin; 12-O-tetradecanoylphorbol; 13-acetate; apoptosis;
D O I
10.1016/S0165-5728(02)00372-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sympathoadrenergic mechanisms may play a role in multiple sclerosis (MS). We examined catecholamine (CA) levels and production and tyrosine hydroxylase (TH) expression in peripheral blood mononuclear cells (PBMCs) from MS patients, and the correlation between CA production and apoptosis in PBMCs. PBMCs from MS patients had increased norepinephrine (NE) levels. However, phytohaemagglutinin (PHA)-stimulated PBMCs from MS patients with active disease synthesized less dopamine (DA) than cells from both healthy controls and patients with inactive disease. PBMCs from patients with inactive disease showed lower expression of TH. Pharmacological inhibition of TH in cultured PBMCs stimulated with PHA reduced the percentage of apoptotic cells. Since a failure of activation-induced apoptosis in immune cells may be involved in MS, it is suggested that altered CA production by PBMCs may be implicated in such dysregulation. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 47 条
[1]  
AMASON BG, 1988, ANN NY ACAD SCI, V540, P585
[2]   Changes in neurotransmitters in multiple sclerosis [J].
Barkhatova V.P. ;
Zavalishin I.A. ;
Askarova L.Sh. ;
Shavratskii V.Kh. ;
Demina E.G. .
Neuroscience and Behavioral Physiology, 1998, 28 (4) :341-344
[3]   Dopamine, a neurotransmitter, influences the immune system [J].
Basu, S ;
Dasgupta, PS .
JOURNAL OF NEUROIMMUNOLOGY, 2000, 102 (02) :113-124
[4]   INNERVATION OF LYMPHOID ORGANS AND IMPLICATIONS IN DEVELOPMENT, AGING, AND AUTOIMMUNITY [J].
BELLINGER, DL ;
LORTON, D ;
FELTEN, SY ;
FELTEN, DL .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (03) :329-344
[5]   DISCOVERY OF ENDOGENOUS CATECHOLAMINES IN LYMPHOCYTES AND EVIDENCE FOR CATECHOLAMINE REGULATION OF LYMPHOCYTE FUNCTION VIA AN AUTOCRINE LOOP [J].
BERGQUIST, J ;
TARKOWSKI, A ;
EKMAN, R ;
EWING, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (26) :12912-12916
[6]   Measurements of catecholamine-mediated apoptosis of immunocompetent cells by capillary electrophoresis [J].
Bergquist, J ;
Josefsson, E ;
Tarkowski, A ;
Ekman, R ;
Ewing, A .
ELECTROPHORESIS, 1997, 18 (10) :1760-1766
[7]   IS MULTIPLE-SCLEROSIS THE EQUIVALENT OF PARKINSONS-DISEASE FOR NORADRENALINE [J].
BERNEFROMELL, K ;
FROMELL, H ;
LUNDKVIST, S ;
LUNDKVIST, P .
MEDICAL HYPOTHESES, 1987, 23 (04) :409-415
[8]   BROMOCRIPTINE THERAPY IN MULTIPLE-SCLEROSIS - AN OPEN-LABEL PILOT-STUDY [J].
BISSAY, V ;
DEKLIPPEL, N ;
HERROELEN, L ;
SCHMEDDING, E ;
BUISSERET, T ;
EBINGER, G ;
DEKEYSER, J .
CLINICAL NEUROPHARMACOLOGY, 1994, 17 (05) :473-476
[9]   CHEMICAL SYMPATHECTOMY AUGMENTS THE SEVERITY OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS [J].
CHELMICKASCHORR, E ;
CHECINSKI, M ;
ARNASON, BGW .
JOURNAL OF NEUROIMMUNOLOGY, 1988, 17 (04) :347-350
[10]  
CHELMICKASCHORR E, 1999, BRAIN BEHAV IMMUN, V13, P271